The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Thu, 12th Dec 2019 14:23

(Alliance News) - The four Oxford Technology venture capital trusts on Thursday reported mixed performances in the third quarter of the current financial year.

Oxford Technology VCT PLC said its net asset value per share as at the end of November stood at 43.9 pence, down from 49.5p as at August 31. This decrease is attributable to the drop in the share price of Scancell Holdings PLC and a fall in the valuation of Getmapping and Select, the company explained.

Oxford Technology VCT shares were untraded in London on Thursday, last closing at 28.50p each.

Oxford Technology 2 VCT PLC also said its NAV performance deteriorated over the third quarter, with NAV per share at November 30 of 30.7p compared to 32.8p as at the end of August. This decrease is attributable to a decline in the valuation of Orthogem and, as for its stable-mate, the drop in the share price of Scancell.

The stock was trading 12% higher at 28.00p a share.

Oxford Technology 4 VCT PLC reported NAV per share as at the end of November of 41.9p, down from 40.4p as at the end of August. This decrease is as a result of a fall in the share price of Castleton Technology PLC, as well as decreases in the valuations of Orthogem and Select.

Oxford Technology 4 VCT shares were untraded at 26.50p each.

By contrast, Oxford Technology 3 VCT PLC said its NAV per share grew to 106.9p at the end of November from 97.8p as of August 31. This increase is due to continuing positive news from Ixaris

and good overall progress by Arecor, the company explained.

The stock was untraded at 48.50p a share.

Scancell shares are down 45% so far in 2019, while Castleton shares are down 22%.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
22 Oct 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Oct 2021 20:41

IN BRIEF: Scancell bases new facility at Oxford Science Park

IN BRIEF: Scancell bases new facility at Oxford Science Park

Read more
5 Oct 2021 22:03

IN BRIEF: Scancell doses first subject in Covidity phase one trial

IN BRIEF: Scancell doses first subject in Covidity phase one trial

Read more
26 Aug 2021 12:53

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

Read more
26 Aug 2021 12:38

Scancell gets MHRA approval for Modi-1 clinical trial

(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initiate the first-in-human phase 1 and 2 clinical study of 'Modi-1'.

Read more
17 Aug 2021 15:32

Scancell chooses needle-free tech for Covid vaccine candidates

(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell has selected the PharmaJet needle-free injection system to administer its two SARS-CoV-2 vaccine candidates for Covid-19, 'SCOV1' and 'SCOV2', in its 'COVIDITY' phase 1 clinical trial, it announced on Tuesday.

Read more
30 Jul 2021 14:24

DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares

DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares

Read more
29 Jul 2021 22:08

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

Read more
28 Jul 2021 22:00

IN BRIEF: Scancell turns once again to Durrant to lead company

IN BRIEF: Scancell turns once again to Durrant to lead company

Read more
22 Jun 2021 15:21

Scancell makes progress with 'Covidity' trial plans

(Sharecast News) - Immunotherapy developer Scancell updated the market on 'Covidity' clinical trial plans, and the publication of preclinical data on two vaccine candidates from the research programme.

Read more
22 Jun 2021 12:14

IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK

IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK

Read more
7 Jun 2021 13:58

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

Read more
7 Jun 2021 10:38

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

Read more
30 Apr 2021 14:30

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

Read more
19 Feb 2021 20:13

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.